Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Edaravone suppresses retinal ganglion cell death in a mouse model of normal tension glaucoma.

Akaiwa K, Namekata K, Azuchi Y, Guo X, Kimura A, Harada C, Mitamura Y, Harada T.

Cell Death Dis. 2017 Jul 13;8(7):e2934. doi: 10.1038/cddis.2017.341.

2.

OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior.

Zike ID, Chohan MO, Kopelman JM, Krasnow EN, Flicker D, Nautiyal KM, Bubser M, Kellendonk C, Jones CK, Stanwood G, Tanaka KF, Moore H, Ahmari SE, Veenstra-VanderWeele J.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):5719-5724. doi: 10.1073/pnas.1701736114. Epub 2017 May 15.

PMID:
28507136
3.

Glutamate transporter type 3 participates in maintaining morphine-induced conditioned place preference.

Wan L, Bi J, Li J, Zuo Z.

Neuroscience. 2017 Mar 6;344:67-73. doi: 10.1016/j.neuroscience.2016.12.038. Epub 2017 Jan 1.

PMID:
28049029
4.

Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis.

Yamada K, Naiki M, Hoshino S, Kitaura Y, Kondo Y, Nomura N, Kimura R, Fukushi D, Yamada Y, Shimozawa N, Yamaguchi S, Shimomura Y, Miura K, Wakamatsu N.

Mol Genet Metab Rep. 2014 Oct 16;1:455-460. eCollection 2014.

5.

Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Zike I, Xu T, Hong N, Veenstra-VanderWeele J.

Neuroscience. 2017 Mar 14;345:256-273. doi: 10.1016/j.neuroscience.2016.09.012. Epub 2016 Sep 16. Review.

PMID:
27646291
6.

Lens glutathione homeostasis: Discrepancies and gaps in knowledge standing in the way of novel therapeutic approaches.

Fan X, Monnier VM, Whitson J.

Exp Eye Res. 2017 Mar;156:103-111. doi: 10.1016/j.exer.2016.06.018. Epub 2016 Jun 29. Review.

PMID:
27373973
7.

Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.

Martinez-Lozada Z, Guillem AM, Robinson MB.

Adv Pharmacol. 2016;76:103-45. doi: 10.1016/bs.apha.2016.01.004. Epub 2016 Mar 24.

8.

The importance of the excitatory amino acid transporter 3 (EAAT3).

Bjørn-Yoshimoto WE, Underhill SM.

Neurochem Int. 2016 Sep;98:4-18. doi: 10.1016/j.neuint.2016.05.007. Epub 2016 May 24. Review.

PMID:
27233497
9.

Neuregulin 1 Promotes Glutathione-Dependent Neuronal Cobalamin Metabolism by Stimulating Cysteine Uptake.

Zhang Y, Hodgson N, Trivedi M, Deth R.

Oxid Med Cell Longev. 2016;2016:3849087. doi: 10.1155/2016/3849087. Epub 2015 Dec 29.

10.

Astroglial glutamate transporters coordinate excitatory signaling and brain energetics.

Robinson MB, Jackson JG.

Neurochem Int. 2016 Sep;98:56-71. doi: 10.1016/j.neuint.2016.03.014. Epub 2016 Mar 21. Review.

PMID:
27013346
11.

LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER.

Brennan BP, Jensen JE, Perriello C, Pope HG Jr, Jenike MA, Hudson JI, Rauch SL, Kaufman MJ.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Feb 1;1(2):116-124.

12.

NEUROBIOLOGICAL EVIDENCE SUPPORTING GLUTAMATE'S ROLE IN PEDIATRIC OBSESSIVE COMPULSIVE DISORDER.

MacMaster FP, Rosenberg DR.

Child Adolesc Psychopharmacol News. 2010 Dec;15(6):6-10. No abstract available.

13.

Striatal magnetic resonance spectroscopy abnormalities in young adult SAPAP3 knockout mice.

Mintzopoulos D, Gillis TE, Robertson HR, Dalia T, Feng G, Rauch SL, Kaufman MJ.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan 1;1(1):39-48.

14.

1,25-Dihydroxyvitamin D induces the glutamate transporter SLC1A1 and alters glutamate handling in non-transformed mammary cells.

Beaudin S, Welsh J.

Mol Cell Endocrinol. 2016 Mar 15;424:34-41. doi: 10.1016/j.mce.2016.01.011. Epub 2016 Jan 14.

15.

Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging Rats.

Arnold JC, Salvatore MF.

ACS Chem Neurosci. 2016 Feb 17;7(2):227-39. doi: 10.1021/acschemneuro.5b00282. Epub 2015 Dec 8.

16.

Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.

Reyes RC, Cittolin-Santos GF, Kim JE, Won SJ, Brennan-Minnella AM, Katz M, Glass GA, Swanson RA.

Neurotherapeutics. 2016 Jan;13(1):217-25. doi: 10.1007/s13311-015-0404-4. Erratum in: Neurotherapeutics. 2016 Jan;13(1):239.

17.

Using mice to model Obsessive Compulsive Disorder: From genes to circuits.

Ahmari SE.

Neuroscience. 2016 May 3;321:121-37. doi: 10.1016/j.neuroscience.2015.11.009. Epub 2015 Nov 10. Review.

18.

Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Afshari P, Myles-Worsley M, Cohen OS, Tiobech J, Faraone SV, Byerley W, Middleton FA.

Mol Neuropsychiatry. 2015 Oct;1(3):125-44. doi: 10.1159/000433599. Epub 2015 Jul 8.

19.

Glutamatergic agents for OCD and related disorders.

Pittenger C.

Curr Treat Options Psychiatry. 2015 Sep;2(3):271-283.

20.

Doxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes.

Park HJ, Baik HJ, Kim DY, Lee GY, Woo JH, Zuo Z, Chung RK.

BMC Anesthesiol. 2015 Aug 8;15:116. doi: 10.1186/s12871-015-0098-5.

Supplemental Content

Support Center